What is the Wegovy Pill?

At Birmingham Weight Loss Clinics, we prioritise patient safety, informed choices, and evidence-based treatment options. The Wegovy pill is an oral formulation of semaglutide, the same active ingredient found in the Wegovy injection, but taken as a once-daily tablet rather than a weekly injection. It was approved by the MHRA in June 2026, making it the first GLP-1 receptor agonist tablet licensed in the UK for weight management.

Like its injectable counterpart, the Wegovy pill is not a substitute for lifestyle modification but is intended to support sustainable weight loss alongside behavioural changes.

Please note that this medication may only be prescribed following a full medical consultation by a qualified prescriber, in line with UK legislation and professional standards set by the General Pharmaceutical Council (GPhC).

woman who lose weight

How the Wegovy Tablet Works

The Wegovy tablet contains semaglutide, which mimics the GLP-1 hormone to help regulate appetite and blood sugar. It works by:

  • Reducing hunger signals in the brain
  • Slowing digestion, increasing fullness after meals
  • Supporting stable blood glucose levels

The tablet must be taken on an empty stomach with a small amount of water, at least 30 minutes before any food, drink, or other medication, to ensure proper absorption.

helps with reduced weight

Wegovy Tablet: Clinical Results

The effectiveness of the Wegovy tablet was established through a 64-week clinical study involving 307 adults living with obesity or overweight with at least one weight-related condition.

Key Results:

  • Mean weight loss: 14% of body weight (~33 lb), compared with 2.4% (~6 lb) on placebo
  • 76% of participants lost at least 5% of their body weight, compared with 31% on placebo
  • Improvements also seen in glycaemic control and cardiometabolic markers
woman on diet

Who Can Take the Wegovy Tablet?

✅ Suitable for adults who:

  • Have a BMI ≥30, or ≥27 with a weight-related condition
  • Can commit to the required daily dosing routine
  • Are not using another GLP-1 medication

❌ Not suitable for those who:

  • Are pregnant, breastfeeding, or trying to conceive
  • Have a history of MTC, MEN2, or pancreatitis
  • Have severe kidney or liver disease

As UK availability is still in early rollout, suitability must be confirmed via consultation. See the NHS guidance on obesity treatment for more.

who should take the wegovy pill

Frequently Asked Questions

The Wegovy tablet is an oral form of semaglutide, taken once daily rather than by weekly injection. It is licensed in the UK for weight management in adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related condition.
The tablet contains semaglutide, which mimics the GLP-1 hormone to reduce hunger, slow digestion, and support stable blood sugar levels. Together, these effects help reduce overall food intake and support sustained weight loss.
Common side effects include nausea, diarrhoea, vomiting, and constipation. These are usually mild and most noticeable when starting treatment or increasing the dose, easing over time as your body adjusts.
Both contain the same active ingredient, semaglutide, but the tablet is taken daily by mouth rather than weekly by injection. The tablet must be taken on an empty stomach with water, at least 30 minutes before food or other medicines.
The tablet is intended for long-term use alongside a healthy diet and exercise. Your progress will be reviewed regularly, and our clinician will advise on whether to continue, adjust, or stop treatment based on your results.
The tablet is licensed for adults with a BMI of 30 or above, or a BMI of 27 or above with a weight-related condition such as high blood pressure or type 2 diabetes. Eligibility will be confirmed during your consultation with our clinician.

Book a Consultation

For more information and to determine whether the Wegovy tablet is a suitable treatment option for you, please book a consultation with our expert team at Birmingham Weight Loss Clinics.

Book Now